Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation — Marija Polovina (2018) | RDL Network
Metabolic syndrome is common in AF patients without overt CAD, and confers an independent, increased risk of MACE, including MI, coronary revascularization, and cardiac death. Given its prognostic implications, prevention and treatment of MetS may reduce the burden of non-thromboembolic complications in AF.
Marrco Vitolo, Vincenzo Livio Malavasi, Marco Proietti, Igor Diemberger, Laurent Fauchier, Francisco Marı́n, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo P. Maggioni, Deirdre A. Lane, Professor Gregory Lip, Giuseppe Boriani
Anne‐Sophie Schuurman, Maxime M. Vroegindewey, Isabella Kardys, Rohit M. Oemrawsingh, Jin M. Cheng, Sanneke de Boer, Héctor M. García‐García, Robert‐Jan van Geuns, Evelyn Regar, Joost Daemen, Nicolas M. Van Mieghem, Patrick W. Serruys, Eric Boersma, K. Martijn Akkerhuis
Yao‐Jun Zhang, Javaid Iqbal, David van Klaveren, Carlos M. Campos, David R. Holmes, A. Pieter Kappetein, Marie-Claude Morice, Adrian Banning, Ever Grech, Christos V. Bourantas, Yoshinobu Onuma, Héctor M. García‐García, Michael J. Mack, Antonio Colombo, Friedrich W. Mohr, Ewout W. Steyerberg, Patrick W. Serruys
Steven P. Marso, Nestor Mercado, Akiko Maehara, Giora Weisz, Gary S. Mintz, John McPherson, François Schiele, Dariusz Dudek, Martin Fahy, Ke Xu, Alexandra J. Lansky, Barry Templin, Zhen Zhang, Bernard De Bruyne, Patrick W. Serruys, Gregg W. Stone
Anne‐Sophie Schuurman, Maxime M. Vroegindewey, Isabella Kardys, Rohit M. Oemrawsingh, Héctor M. García‐García, Robert‐Jan van Geuns, Evelyn Regar, Nicolas M. Van Mieghem, Jürgen Ligthart, Patrick W. Serruys, Eric Boersma, K. Martijn Akkerhuis
Discussion(0)
No comments yet. Be the first to comment.